Minetta C Liu, MD

Professor, Rochester, MN, Medical Oncology

EmailLiu.Minetta@mayo.edu

5084 Citations
30 Scopus h-Index

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Minetta C Liu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Breast Neoplasms Medicine & Life Sciences

Triple Negative Breast Neoplasms Medicine & Life Sciences

Circulating Neoplastic Cells Medicine & Life Sciences

Neoplasms Medicine & Life Sciences

Biomarkers Medicine & Life Sciences

Therapeutics Medicine & Life Sciences

Drug Therapy Medicine & Life Sciences

Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

5084 Citations
30 Scopus h-Index
63 Article
3 Review article
2 Chapter
1 Letter

Available and emerging molecular markers in the clinical management of breast cancer

Giridhar, K. V. & Liu, M. C., Oct 3 2019, In : Expert Review of Molecular Diagnostics. 19, 10, p. 919-928 10 p.

Research output: Contribution to journal › Review article

Biomarkers

Breast Neoplasms

Microsatellite Instability

Mutation

Neoadjuvant Therapy

Circulating Tumor DNA and Hepatocellular Carcinoma

Yang, J. D., Liu, M. C. & Kisiel, J. B., Jan 1 2019, In : Seminars in Liver Disease. 39, 4, p. 452-462 11 p.

Research output: Contribution to journal › Article

Hepatocellular Carcinoma

DNA

Neoplasms

Methylation

Technology

First-line doublet chemotherapy for metastatic triple-negative breast cancer: Circulating tumor cell analysis of the tnAcity trial

Liu, M. C., Janni, W., Georgoulias, V., Yardley, D. A., Harbeck, N., Wei, X., McGovern, D. & Beck, R., Jan 1 2019, In : Cancer Management and Research. 11, p. 10427-10433 7 p.

Research output: Contribution to journal › Article

Open Access

Triple Negative Breast Neoplasms

Circulating Neoplastic Cells

Drug Therapy

gemcitabine

Disease-Free Survival

Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy

Vasmatzis, G., Liu, M. C., Reganti, S., Feathers, R. W., Smadbeck, J., Johnson, S. H., Schaefer Klein, J. L., Harris, F. R., Yang, L., Kosari, F., Murphy, S. J., Borad, M. J., Thompson, E. A., Cheville, J. C. & Anastasiadis, P. Z., Jan 1 2019, (Accepted/In press) In : Mayo Clinic proceedings.

Research output: Contribution to journal › Article

Open Access

Neoplasms

Mutation

Therapeutics

Precision Medicine

Preclinical Drug Evaluations

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

Russell, S. J., Babovic-Vuksanovic, D., Bexon, A., Cattaneo, R., Dingli, D., Dispenzieri, A., Deyle, D. R., Federspiel, M. J., Fielding, A., Galanis, E., Lacy, M. Q., Leibovich, B. C., Liu, M. C., Muñoz-Alía, M., Miest, T. C., Molina, J. R., Mueller, S., Okuno, S. H., Packiriswamy, N., Peikert, T. & 6 others, Raffel, C., Van Rhee, F., Ungerechts, G., Young, P. R., Zhou, Y. & Peng, K. W., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journal › Review article

Open Access

Oncolytic Virotherapy

Measles

Vaccination

Measles virus

Immunity